A SHORT REVIEW ON HERBAL PRODUCTS ACTING AS ANTI-HIV AGENTS
DOI:
https://doi.org/10.22159/ijcpr.2021v13i4.42740Keywords:
HIV, Natural productsAbstract
Over the previous decade, considerable advancement has been made in research on the regular items having hostility to HIV movement. An assortment of optional metabolites got from natural origin demonstrated mild to strong anti-HIV properties. Nature has consistently given a wellspring of medications to different sicknesses. Various therapeutic plants have been accounted for to have against HIV. The investigation of regular items in biomedical exploration is not an advanced idea. vast numbers of the best medicinal therapeutic drugs are extracted from natural products and concentrated in HIV/AIDS. The Biomedical review has a long history of disclosure depending on the screen of medicinal spices and conventional medicines. It is essential to remember the clinical study convention to conclude Therapies based on these herbal products combat the negative view of alternative medicine as therapeutic remedies. This review addressed different herbal products that are having anti-HIV properties.
Downloads
Download data is not yet available.
References
1. Luciw PA. Human immunodeficiency viruses and their replication. In: Fields BN. Editor. Virology. 3rd ed. Philadelphia: Lippincott-Raven; 1996. p. 1881–952.
2. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, et al. Origin of HIV-1 in the chimpanzee pan troglodytes. Nature 1999;397:436–41.
3. Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med 2011;1:a006841.
4. Sepkowitz KA. AIDS-the first 20 y. New England J Med 2001;344:1764–72.
5. UNAIDS, WHO, AIDS epidemic update; 2007.
6. Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harbor Perspectives Med 2011;1:a006841.
7. Gallo RC. A reflection on HIV/AIDS research after 25 y. Retrovirology 2006;3:72.
8. Rajandeep Kaur, Rajeev Kharb. Anti-HIV potential medicinally important plants. Int J Pharma Bio Sci 2011;2:387-98.
9. Mankil Jung, Seokjoon Lee, Hanjo Kim, Haesook Kim. Recent studies on natural products as anti-HIV agents. Curr Med Chem 2000;7:649-61.
10. De Clercq E. Antiviral therapy for human immunodeficiency virusinfections. Clin Microbiol Rev 1995;8:200–39.
11. Ohtake N, Nakai Y, Yamamoto M, Sakakibara I, Takeda S, Amagaya S, et al. Separation and isolation methods for analysis of the active principles of Sho-saiko-to (SST) oriental medicine. J Chromatogr B 2004;812:135–48.
12. Cos P, Maes L, Vlietinck A, Pieters L. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection–an update (1998–2007). Planta Med 2008; 74:1323-37.
13. Li HY, Sun NJ, Kashiwada Y, Sun L, Snider JV, Cosentino LM, et al. Anti-AIDS agents, 9. Suberosol, a new C31 lanostane-type triterpene and anti-HIV principle from polyalthia suberosa. J Nat Prod 1993;56:1130–3.
14. Chattopadhyay D, Naik TN. Antivirals of ethnomedicinal origin: structure-activity relationship and scope. Mini Rev Med Chem 2007;7:275-301.
15. H Nakane, M Arisawa, A Fujita, S Koshimura, K Ono. Inhibition of HIV-reverse transcriptase activity by some phloroglucinol derivatives. FEBS Lett 1991;286:83–5.
16. Rimando AM, Pezzuto JM, Farnsworth NR, Santisuk T, Reutrakul V, Kawanishi K. New lignans from anogeissus acuminata with HIV-1 reverse transcriptase inhibitory activity. J Nat Prod 1994;57:896-904.
17. Rimando AM, Pezzuto JM, Farnsworth NR, Santisuk T, Reutrakul V, Kawanishi K. New lignans from anogeissus acuminata with HIV-1 reverse transcriptase inhibitory activity. J Nat Prod 1994;57:896-904.
18. Ogata T, Higuchi H, Mochida S, Matsumoto H, Kato A, Endo T, et al. HIV-1 reverse transcriptase inhibitor from phyllanthus niruri. AIDS Res Hum Retrovir 1992;8:1937–44.
19. Kashman Y, Gustafson KR, Fuller RW, Cardellina JH, McMahon JB, Currens MJ, et al. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J Med Chem 1992;35:2735-43.
20. Kashman Y, Gustafson KR, Fuller RW, Cardellina JH, McMahon JB, Currens MJ, et al. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J Med Chem 1992;35:2735-43.
21. Hu K, Kobayashi H, Dong A, Iwasaki S, Yao X. Antifungal, antimitotic and anti-HIV-1 agents from the roots of Wikstroemia indica. Planta Med 2000;66:564–7.
22. Chang CW, Lin MT, Lee SS, Liu KCC, Hsu FL, Lin JY. Differential inhibition of reverse transcriptase and cellular DNA polymerase-? activities by lignans isolated from Chinese herbs, phyllanthus myrtifolius moon, and tannins from lonicera japonica thunb and castanopsis hystrix. Antiviral Res 1995;27:367-74.
23. Chen DF, Zhang SX, Wang HK, Zhang SY, Sun QZ, Cosentino LM, et al. Novel anti-HIV lancilactone C and related triterpenes from Kadsura lancilimba. J Nat Prod 1999;62:94–7.
24. Chinsembu KC. Chemical diversity and activity profiles of HIV-1 reverse transcriptase inhibitors from plants. Rev Brasileira Farmacognosia 2019;29:504-28.
25. Rukachaisirikul V, Pailee P, Hiranrat A, Tuchinda P, Yoosook C, Kasisit J, et al. Anti-HIV-1 protostane triterpenes and digeranylbenzophenone from trunk bark and stems of garcinia speciosa. Planta Med 2003;69:1141–6.
26. Kaur R, Sharma P, Gupta GK, Ntie Kang F, Kumar D. Structure-activity-relationship and mechanistic insights for anti-HIV natural products. Molecules 2020;25:2070.
27. Gulakowski RJ, McMahon JB, Buckheit RW, Gustafson KR, Boyd MR. Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV). Antiviral Res 1997;33:87–97.
28. Hattori M, Ma CM, Wei Y, Dine RSE, Sato N. Survey of anti-HIV and anti-HCV compounds from natural sources. Can Chem Trans 2013;1:116-40.
29. Decosterd LA, Parsons IC, Gustafson KR, Cardellina JH, Mcmahon JB, Cragg GM, et al. HIV inhibitory natural products. 11. Structure, absolute stereochemistry, and synthesis of conocurvone, a potent, novel HIV inhibitory naphthoquinone trimer from a conospermum sp. J Am Chem Soc 1993;115:6673–9.
30. Raissi A, Arbabi M, Roustakhiz J, Hosseini M. Haplophyllum tuberculatum: an overview. J Herb Med Pharmacol 2016;5:125-30.
31. El-Mekkawy S, Meselhy MR, Nakamura N, Hattori M, Kawahata T, Otake T. Anti-HIV-1 phorbol esters from the seeds of croton tiglium. Phytochemistry 2000;53:457–64.
32. https://pubchem.ncbi.nlm.nih.gov/compound/Macluraxanthone-B#section=BioAssay- [Last accessed on 10 Apr 2021]
33. Abd-Elazem IS, Chen HS, Bates RB, Huang RC. Isolation of two highly potent and non-toxic inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase from salvia miltiorrhiza. Antiviral Res 2002;55:91–106.
34. Xu HX, Wan M, Dong H, BuT PPH, Foo LY. Inhibitory activity of flavonoids and tannins against HIV-1 protease. Biol Pharm Bull 2000;23:1072-6.
35. Kashiwada Y, Nishizawa M, Yamagishi T, Tanaka T, Nonaka GI, Cosentino LM, et al. Anti-AIDS Agents, 18. sodium and potassium salts of caffeic acid tetramers from Arnebia euchroma as anti-HIV agents. J Nat Prod 1995;58:392–400.
36. Kaur R, Sharma P, Gupta GK, Ntie Kang F, Kumar D. Structure-activity-relationship and mechanistic insights for anti-HIV natural products. Molecules 2020;25:2070.
37. Yao Haur K, Li-Ming Yang K. Antitumour and anti-AIDS triterpenes from celastrus hindsii. Phytochemistry 1997;44:1275–81.
38. Lin YM, Anderson H, Flavin MT, Pai YHS, Mata Greenwood E, Pengsuparp T, et al. In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and garcinia multiflora. J Nat Prod 1997;60:884-8.
39. Roth GN, Chandra A, Nair MG. Novel bioactivities of curcuma longa constituents. J Nat Prod 1998;61:542–5.
40. Chen DF, Zhang SX, Wang HK, Zhang SY, Sun QZ, Cosentino LM, et al. Novel anti-HIV lancilactone C and related triterpenes from Kadsura lancilimba. J Nat Prod 1999;62:94-7.
41. Emini EA, Fan HY. Immunological and pharmacological approaches to the control of retroviral infections. In: Coffin. editors. Retroviruses; 1999. p. 637–706.
42. http://www.caymanchem.com/pdfs/10272.pdf [Last accessed on 10 Apr 2021]
43. Pang XF, Zhang LH, Bai F, Wang NP, Garner RE, McKallip RJ, et al. Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression 2015;9:6043-54.
44. http://en.cnki.com.cn/Article_en/CJFDTotal-ZXYZ200805011.htm [Last accessed on 10 Apr 2021]
45. Das S, Sarmah S, Lyndem S, Roy AS. An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. J Biomol Struct Dyn 2020;13:1–11.
46. Fesen MR, Kohn KW, Leteurtre F, Pommier Y. Inhibitors of human immunodeficiency virus integrase. Proc Natl Acad Sci 1993;90:2399-403.
47. Roth GN, Chandra A, Nair MG. Novel bioactivities of curcuma longa constituents. J Nat Prod 1998;61:542–5.
48. Chattopadhyay D, Naik TN. Antivirals of ethnomedicinal origin: structure-activity relationship and scope. Mini Rev Med Chem 2007;7:275-301.
49. Kashiwada Y, Wang HK, Nagao T, Kitanaka S, Yasuda I, Fujioka T, et al. Anti-AIDS agents. 30 anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids. J Nat Prod 1998;61;1090–5.
50. Jung M, Lee S, Kim H. Recent studies on natural products as anti-HIV agents. Curr Med Chem 2000;7:649-61.
51. El-Mekkawy S, Meselhy MR, Nakamura N, Hattori M, Kawahata T, Otake T. Anti-HIV-1 phorbol esters from the seeds of croton tiglium. Phytochemistry 2000;53:457–64.
52. Chattopadhyay D, Naik TN. Antivirals of ethnomedicinal origin: structure-activity relationship and scope. Mini Rev Med Chem 2007;7:275-301.
53. Emini EA, Fan HY. Immunological and pharmacological approaches to the control of retroviral infections. In: Coffin. editors. Retroviruses; 2007. p. 637–706.
54. http://www.hivandhepatitis.com/recent/2007/1101607_a.html. [Last accessed on 10 Apr 2021]
55. Pang XF, Zhang LH, Bai F, Wang NP, Garner RE, McKallip RJ, et al. Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats. Drug Des Dev Ther 2015;9:6043–54.
56. Das S, Sarmah S, Lyndem S, Roy AS. An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. J Biomol Struct Dyn 2020;13:1–11.
2. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, et al. Origin of HIV-1 in the chimpanzee pan troglodytes. Nature 1999;397:436–41.
3. Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med 2011;1:a006841.
4. Sepkowitz KA. AIDS-the first 20 y. New England J Med 2001;344:1764–72.
5. UNAIDS, WHO, AIDS epidemic update; 2007.
6. Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harbor Perspectives Med 2011;1:a006841.
7. Gallo RC. A reflection on HIV/AIDS research after 25 y. Retrovirology 2006;3:72.
8. Rajandeep Kaur, Rajeev Kharb. Anti-HIV potential medicinally important plants. Int J Pharma Bio Sci 2011;2:387-98.
9. Mankil Jung, Seokjoon Lee, Hanjo Kim, Haesook Kim. Recent studies on natural products as anti-HIV agents. Curr Med Chem 2000;7:649-61.
10. De Clercq E. Antiviral therapy for human immunodeficiency virusinfections. Clin Microbiol Rev 1995;8:200–39.
11. Ohtake N, Nakai Y, Yamamoto M, Sakakibara I, Takeda S, Amagaya S, et al. Separation and isolation methods for analysis of the active principles of Sho-saiko-to (SST) oriental medicine. J Chromatogr B 2004;812:135–48.
12. Cos P, Maes L, Vlietinck A, Pieters L. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection–an update (1998–2007). Planta Med 2008; 74:1323-37.
13. Li HY, Sun NJ, Kashiwada Y, Sun L, Snider JV, Cosentino LM, et al. Anti-AIDS agents, 9. Suberosol, a new C31 lanostane-type triterpene and anti-HIV principle from polyalthia suberosa. J Nat Prod 1993;56:1130–3.
14. Chattopadhyay D, Naik TN. Antivirals of ethnomedicinal origin: structure-activity relationship and scope. Mini Rev Med Chem 2007;7:275-301.
15. H Nakane, M Arisawa, A Fujita, S Koshimura, K Ono. Inhibition of HIV-reverse transcriptase activity by some phloroglucinol derivatives. FEBS Lett 1991;286:83–5.
16. Rimando AM, Pezzuto JM, Farnsworth NR, Santisuk T, Reutrakul V, Kawanishi K. New lignans from anogeissus acuminata with HIV-1 reverse transcriptase inhibitory activity. J Nat Prod 1994;57:896-904.
17. Rimando AM, Pezzuto JM, Farnsworth NR, Santisuk T, Reutrakul V, Kawanishi K. New lignans from anogeissus acuminata with HIV-1 reverse transcriptase inhibitory activity. J Nat Prod 1994;57:896-904.
18. Ogata T, Higuchi H, Mochida S, Matsumoto H, Kato A, Endo T, et al. HIV-1 reverse transcriptase inhibitor from phyllanthus niruri. AIDS Res Hum Retrovir 1992;8:1937–44.
19. Kashman Y, Gustafson KR, Fuller RW, Cardellina JH, McMahon JB, Currens MJ, et al. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J Med Chem 1992;35:2735-43.
20. Kashman Y, Gustafson KR, Fuller RW, Cardellina JH, McMahon JB, Currens MJ, et al. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J Med Chem 1992;35:2735-43.
21. Hu K, Kobayashi H, Dong A, Iwasaki S, Yao X. Antifungal, antimitotic and anti-HIV-1 agents from the roots of Wikstroemia indica. Planta Med 2000;66:564–7.
22. Chang CW, Lin MT, Lee SS, Liu KCC, Hsu FL, Lin JY. Differential inhibition of reverse transcriptase and cellular DNA polymerase-? activities by lignans isolated from Chinese herbs, phyllanthus myrtifolius moon, and tannins from lonicera japonica thunb and castanopsis hystrix. Antiviral Res 1995;27:367-74.
23. Chen DF, Zhang SX, Wang HK, Zhang SY, Sun QZ, Cosentino LM, et al. Novel anti-HIV lancilactone C and related triterpenes from Kadsura lancilimba. J Nat Prod 1999;62:94–7.
24. Chinsembu KC. Chemical diversity and activity profiles of HIV-1 reverse transcriptase inhibitors from plants. Rev Brasileira Farmacognosia 2019;29:504-28.
25. Rukachaisirikul V, Pailee P, Hiranrat A, Tuchinda P, Yoosook C, Kasisit J, et al. Anti-HIV-1 protostane triterpenes and digeranylbenzophenone from trunk bark and stems of garcinia speciosa. Planta Med 2003;69:1141–6.
26. Kaur R, Sharma P, Gupta GK, Ntie Kang F, Kumar D. Structure-activity-relationship and mechanistic insights for anti-HIV natural products. Molecules 2020;25:2070.
27. Gulakowski RJ, McMahon JB, Buckheit RW, Gustafson KR, Boyd MR. Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV). Antiviral Res 1997;33:87–97.
28. Hattori M, Ma CM, Wei Y, Dine RSE, Sato N. Survey of anti-HIV and anti-HCV compounds from natural sources. Can Chem Trans 2013;1:116-40.
29. Decosterd LA, Parsons IC, Gustafson KR, Cardellina JH, Mcmahon JB, Cragg GM, et al. HIV inhibitory natural products. 11. Structure, absolute stereochemistry, and synthesis of conocurvone, a potent, novel HIV inhibitory naphthoquinone trimer from a conospermum sp. J Am Chem Soc 1993;115:6673–9.
30. Raissi A, Arbabi M, Roustakhiz J, Hosseini M. Haplophyllum tuberculatum: an overview. J Herb Med Pharmacol 2016;5:125-30.
31. El-Mekkawy S, Meselhy MR, Nakamura N, Hattori M, Kawahata T, Otake T. Anti-HIV-1 phorbol esters from the seeds of croton tiglium. Phytochemistry 2000;53:457–64.
32. https://pubchem.ncbi.nlm.nih.gov/compound/Macluraxanthone-B#section=BioAssay- [Last accessed on 10 Apr 2021]
33. Abd-Elazem IS, Chen HS, Bates RB, Huang RC. Isolation of two highly potent and non-toxic inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase from salvia miltiorrhiza. Antiviral Res 2002;55:91–106.
34. Xu HX, Wan M, Dong H, BuT PPH, Foo LY. Inhibitory activity of flavonoids and tannins against HIV-1 protease. Biol Pharm Bull 2000;23:1072-6.
35. Kashiwada Y, Nishizawa M, Yamagishi T, Tanaka T, Nonaka GI, Cosentino LM, et al. Anti-AIDS Agents, 18. sodium and potassium salts of caffeic acid tetramers from Arnebia euchroma as anti-HIV agents. J Nat Prod 1995;58:392–400.
36. Kaur R, Sharma P, Gupta GK, Ntie Kang F, Kumar D. Structure-activity-relationship and mechanistic insights for anti-HIV natural products. Molecules 2020;25:2070.
37. Yao Haur K, Li-Ming Yang K. Antitumour and anti-AIDS triterpenes from celastrus hindsii. Phytochemistry 1997;44:1275–81.
38. Lin YM, Anderson H, Flavin MT, Pai YHS, Mata Greenwood E, Pengsuparp T, et al. In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and garcinia multiflora. J Nat Prod 1997;60:884-8.
39. Roth GN, Chandra A, Nair MG. Novel bioactivities of curcuma longa constituents. J Nat Prod 1998;61:542–5.
40. Chen DF, Zhang SX, Wang HK, Zhang SY, Sun QZ, Cosentino LM, et al. Novel anti-HIV lancilactone C and related triterpenes from Kadsura lancilimba. J Nat Prod 1999;62:94-7.
41. Emini EA, Fan HY. Immunological and pharmacological approaches to the control of retroviral infections. In: Coffin. editors. Retroviruses; 1999. p. 637–706.
42. http://www.caymanchem.com/pdfs/10272.pdf [Last accessed on 10 Apr 2021]
43. Pang XF, Zhang LH, Bai F, Wang NP, Garner RE, McKallip RJ, et al. Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression 2015;9:6043-54.
44. http://en.cnki.com.cn/Article_en/CJFDTotal-ZXYZ200805011.htm [Last accessed on 10 Apr 2021]
45. Das S, Sarmah S, Lyndem S, Roy AS. An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. J Biomol Struct Dyn 2020;13:1–11.
46. Fesen MR, Kohn KW, Leteurtre F, Pommier Y. Inhibitors of human immunodeficiency virus integrase. Proc Natl Acad Sci 1993;90:2399-403.
47. Roth GN, Chandra A, Nair MG. Novel bioactivities of curcuma longa constituents. J Nat Prod 1998;61:542–5.
48. Chattopadhyay D, Naik TN. Antivirals of ethnomedicinal origin: structure-activity relationship and scope. Mini Rev Med Chem 2007;7:275-301.
49. Kashiwada Y, Wang HK, Nagao T, Kitanaka S, Yasuda I, Fujioka T, et al. Anti-AIDS agents. 30 anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids. J Nat Prod 1998;61;1090–5.
50. Jung M, Lee S, Kim H. Recent studies on natural products as anti-HIV agents. Curr Med Chem 2000;7:649-61.
51. El-Mekkawy S, Meselhy MR, Nakamura N, Hattori M, Kawahata T, Otake T. Anti-HIV-1 phorbol esters from the seeds of croton tiglium. Phytochemistry 2000;53:457–64.
52. Chattopadhyay D, Naik TN. Antivirals of ethnomedicinal origin: structure-activity relationship and scope. Mini Rev Med Chem 2007;7:275-301.
53. Emini EA, Fan HY. Immunological and pharmacological approaches to the control of retroviral infections. In: Coffin. editors. Retroviruses; 2007. p. 637–706.
54. http://www.hivandhepatitis.com/recent/2007/1101607_a.html. [Last accessed on 10 Apr 2021]
55. Pang XF, Zhang LH, Bai F, Wang NP, Garner RE, McKallip RJ, et al. Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats. Drug Des Dev Ther 2015;9:6043–54.
56. Das S, Sarmah S, Lyndem S, Roy AS. An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. J Biomol Struct Dyn 2020;13:1–11.
